MIRA INFORM REPORT

 

 

Report No. :

301520

Report Date :

27.01.2015

 

IDENTIFICATION DETAILS

 

Name :

CENTURION REMEDIES PRIVATE LIMITED

 

CENTURION LABORATORIES (A DIVISION OF CENTURION REMEDIES PRIVATE LIMITED)

 

 

Registered Office :

G/5, Industrial Estate, Gorwa, Baroda – 390016, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

21.04.2003

 

 

Com. Reg. No.:

04-042254

 

 

Capital Investment / Paid-up Capital :

Rs.2.500 Millions

 

 

CIN No.:

[Company Identification No.]

U24231GJ2003PTC042254

 

 

TIN No.:

Not Available

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

Not Available

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical Formulations.

 

 

No. of Employees :

200 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 220000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

General financial position of the company seems to be sound and healthy. Profitability of the company is fair

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and condition.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2014

 

Country Name

Previous Rating

(30.06.2014)

Current Rating

(30.09.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Ms. Nirmala

Designation :

Sales Manager

Contact No.:

91-265-2282061

Date :

19.01.2015

LOCATIONS

 

Registered Office :

G/5, Industrial Estate, Gorwa, Baroda – 390016, Gujarat, India

Tel. No.:

91-265-2282061/ 2281074/ 3290522/ 2282061/ 2282065

Mobile No.:

91-9825203550 (Mr. Dhruval Patel)

Fax No.:

91-265-2280436

E-Mail :

info@centurionremedies.com

centurionbrd@yahoo.co.in

cen_lab@rediffmail.com

cen_lab@sify.com

info@centurionremedies.com

Website :

www.centurionremedies.com

Location :

Owned

Locality :

Industrial

 

 

Factory :

G-5, F-19, H-10, Industrial Estate, BIDC, Gorwa, Baroda, Vadodara - 390016, Gujarat, India

 

 

DIRECTORS

 

As on 30.09.2014

 

Name :

Mr. Ambalal Vanarasidas Patel

Designation :

Managing Director

Address :

Mahipat Opposite 1, Amar Park Society, Near Bank of India Society, Nizampura, Vadodara – 390002,  Gujarat, India

Date of Appointment :

21.04.2003

DIN No.:

00462011

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231GJ2003PTC042254

CENTURION REMEDIES PRIVATE LIMITED

Managing director

15/06/2012

21/04/2003

-

Active

NO

2

U73100GJ2006PTC049620

CENTURION LABORATORIES PRIVATE LIMITED

Additional director

14/02/2011

14/02/2011

-

Active

NO

3

U24232GJ2012PTC072346

ADC PHARMACEUTICALS PRIVATE LIMITED

Director

17/10/2012

17/10/2012

-

Active

NO

 

 

Name :

Mr. Dhruval Jayantilal Patel

Designation :

Director

Address :

Mahipat Opposite 1, Amar Park Society, Near Bank of India Society, Nizampura, Vadodara – 390002,  Gujarat, India

Date of Appointment :

21.04.2003

DIN No.:

00448083

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231GJ2003PTC042254

CENTURION REMEDIES PRIVATE LIMITED

Director

21/04/2003

21/04/2003

-

Active

NO

2

U73100GJ2006PTC049620

CENTURION LABORATORIES PRIVATE LIMITED

Managing director

15/06/2012

14/02/2011

-

Active

NO

3

U24232GJ2012PTC072346

ADC PHARMACEUTICALS PRIVATE LIMITED

Director

17/10/2012

17/10/2012

-

Active

NO

 

 

Name :

Mr. Patel Chetan Jayantilal

Designation :

Director

Address :

Mahipat  Opposite 1, Amar Park Society, Near Bank of India Society, Nizampura, Vadodara - 390002, Gujarat, India

Date of Appointment :

18.07.2014

DIN No.:

06373484

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24232GJ2012PTC072346

ADC PHARMACEUTICALS PRIVATE LIMITED

Director

17/10/2012

17/10/2012

-

Active

NO

2

U24231GJ2003PTC042254

CENTURION REMEDIES PRIVATE LIMITED

Director

18/07/2014

18/07/2014

-

Active

NO

 

 

Name :

Mr. Mahipat Ambalalbhai Patel

Designation :

Director

Address :

Mahipat  Opposite 1, Amar Park Society, Near Bank of India Society, Nizampura, Vadodara - 390002, Gujarat, India

Date of Appointment :

01.07.2013

DIN No.:

06373494

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24232GJ2012PTC072346

ADC PHARMACEUTICALS PRIVATE LIMITED

Director

17/10/2012

17/10/2012

-

Active

NO

2

U73100GJ2006PTC049620

CENTURION LABORATORIES PRIVATE LIMITED

Director

20/02/2013

20/02/2013

-

Active

NO

3

U24231GJ2003PTC042254

CENTURION REMEDIES PRIVATE LIMITED

Director

01/07/2013

01/07/2013

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Ms. Nirmala

Designation :

Sales Manager

 

 

MAJOR SHAREHOLDERS

 

As on 30.09.2014

 

Names of Shareholders

 

No. of Shares

A. V. Patel

 

18000

L. A. Patel

 

9000

Rohi Patel

 

22490

Tejal Patel

 

22310

Renuka M. Patel

 

24695

Mittal N. Patel

 

2

Dhruval J. Patel

 

45000

Chetan J. Patel

 

2

Mukesh B. Patel

 

9000

J.V.Patel

 

2

Amrutben J. Patel

 

2

A.V.Patel H.U.F.

 

27002

Mahipat Patel

 

36480

Nupur A. Patel

 

36015

Total

 

250000

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2014

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical Formulations.

 

 

Products :

Pharmaceutical Formulations

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

Not Divulged 

 

 

Imports :

 

Products :

Vitamins and Minerals Products

Countries :

  • China
  • Russia
  • South East Asian Countries

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

PRODUCTION STATUS – NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Not Divulged 

 

 

Customers :

Not Divulged 

 

 

No. of Employees :

200 (Approximately)

 

 

Bankers :

·         Indusind Bank Limited, Ground Floor, and 1st Floor, Gold Croft Vishwas Colony, Jetalpur Road, Baroda – 390005, Gujarat, India

Tel No.: 91-265-2332409/ 2332418

·         Bank of Baroda, I.E. Gorwa Branch, Gorwa, Baroda – 390016, Gujarat, India

 

 

Facilities :

SECURED LOANS

31.03.2014

Rs. In Millions

31.03.2013

Rs. In Millions

LONG TERM BORROWINGS

 

 

From lndusind Bank Limited

(Secured against the hypothecation of machinery)

23.385

29.097

From A. U. Financer

(Secured against the hypothecation of Vehicle)

0.036

0.000

From IClCl Bank

(Secured against the hypothecation of Vehicle)

1.115

0.000

SHORT TERM BORROWINGS

 

 

From lndusind Bank Limited

(Secured against the hypothecation of stocks and other current assets)

28.011

49.122

From LIC

(Secured against the pledge of LIC policies )

5.163

0.000

Total

57.710

78.219

 

 

 

Auditors :

 

Name :

H. Thakore and Company

Chartered Accountants

Address :

A-102, Mangalmurti  Apartments, Behind New Alka Restaurant, R. C. Dutt Road, Alkapuri, Vadodara – 390005, Gujarat, India

Mobile No.:

91-9825491180

E-Mail :

ca.hirday@vahoo.co.in

PAN No.:

ACJPT7705J

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Sister Concern :

Not Divulged 

 

 

CAPITAL STRUCTURE

 

As on 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000

Equity Shares

Rs.10/- each

Rs.2.500 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000

Equity Shares

Rs.10/- each

Rs.2.500 Millions

 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

2.500

2.500

1.802

(b) Reserves & Surplus

74.656

59.124

33.985

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

77.156

61.624

35.787

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

24.536

29.097

0.314

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

24.536

29.097

0.314

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

33.174

49.122

58.618

(b) Trade payables

160.384

123.553

88.261

(c) Other current liabilities

6.014

2.465

1.376

(d) Short-term provisions

5.428

5.065

4.766

Total Current Liabilities (4)

205.000

180.205

153.021

 

 

 

 

TOTAL

306.692

270.926

189.122

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

59.686

41.646

36.651

(ii) Intangible Assets

0.050

0.050

0.050

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

4.507

0.000

(b) Non-current Investments

3.647

3.647

3.772

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

63.383

49.850

40.473

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

54.246

37.067

29.443

(c) Trade receivables

94.219

78.651

57.895

(d) Cash and cash equivalents

50.119

64.236

31.633

(e) Short-term loans and advances

44.725

41.122

29.678

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

243.309

221.076

148.649

 

 

 

 

TOTAL

306.692

270.926

189.122

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

607.320

455.897

300.588

 

 

Other Income

16.392

17.821

8.062

 

 

TOTAL                                         (A)

623.712

473.718

308.650

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Consumption of Raw Materials

354.260

296.344

201.429

 

 

Consumption of Packing Materials

110.464

68.671

28.309

 

 

Changes in Inventories of finished goods, work-in-progress and stock-in-trade

(5.114)

(5.619)

(1.894)

 

 

Cost Manufacturing Expenses

41.336

34.111

24.337

 

 

Administrative Expenses

22.043

17.547

14.472

 

 

Selling and Distribution Expenses

31.959

18.462

13.763

 

 

Employee Benefits Expenses

21.478

12.720

5.782

 

 

Prior Period Expenses

0.000

0.000

0.020

 

 

TOTAL                                         (B)

576.426

442.236

286.218

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

47.286

31.482

22.432

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

13.059

8.772

6.019

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

34.227

22.710

16.413

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

18.669

6.325

4.590

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX (E-F)                  (G)     

15.558

16.385

11.823

 

 

 

 

 

Less

TAX                                                                  (H)

6.116

5.065

4.766

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX (G-H)                    (I)

9.442

11.320

7.057

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

22.413

11.093

4.036

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

31.855

22.413

11.093

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

244.984

167.399

106.568

 

TOTAL EARNINGS

244.984

167.399

106.568

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

37.77

44.28

39.16

 

Expected Sales (2014-2015): Rs.60.000 Millions

 

The above information has been parted by Ms. Nirmala

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

1.55

2.48

2.35

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

7.79

6.91

7.46

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

5.13

6.24

6.38

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.20

0.27

0.33

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.75

1.27

1.65

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.19

1.23

0.97

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Share Capital

1.802

2.500

2.500

Reserves & Surplus

33.985

59.124

74.656

Share Application money pending allotment

0.000

0.000

0.000

Net worth

35.787

61.624

77.156

 

 

 

 

Long Term borrowings

0.314

29.097

24.536

Short Term borrowings

58.618

49.122

33.174

Total borrowings

58.932

78.219

57.710

Debt/Equity ratio

1.647

1.269

0.748

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

300.588

455.897

607.320

 

 

51.668

33.214

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

300.588

455.897

607.320

Profit

7.057

11.320

9.442

 

2.35%

2.48%

1.55%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

No

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10388504

11/11/2014 *

112,798,000.00

Indusind Bank Limited

Ground Floor And First Floor, Gold Croft,, Vishwas Colony, Jetalpur Road,, Vadodara, Gujarat - 390005, India

C35212802

2

10378854

11/11/2014 *

112,798,000.00

Indusind Bank Limited

Ground Floor And First Floor, Gold Croft,, Vishwas Colony, Jetalpur Road,, Vadodara, Gujarat - 390005, India

C35212273

*Date of modification Charges

 

 


FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Computer

·         Vehicles

·         Furniture and Fixture

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :  No press reports / filings exists on the subject.

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.69

UK Pound

1

Rs.93.33

Euro

1

Rs.71.49

 

 

INFORMATION DETAILS

 

Information Gathered by :

SNJ

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

VNT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILITY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.